Cargando…
Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
Most cancer vaccines are unsuccessful in eliciting clinically relevant effects. Without using exogenous antigens and adoptive cells, we show a concept of utilizing biologically reprogrammed cytomembranes of the fused cells (FCs) derived from dendritic cells (DCs) and cancer cells as tumor vaccines....
Autores principales: | Liu, Wen-Long, Zou, Mei-Zhen, Liu, Tao, Zeng, Jin-Yue, Li, Xue, Yu, Wu-Yang, Li, Chu-Xin, Ye, Jing-Jie, Song, Wen, Feng, Jun, Zhang, Xian-Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642123/ https://www.ncbi.nlm.nih.gov/pubmed/31324770 http://dx.doi.org/10.1038/s41467-019-11157-1 |
Ejemplares similares
-
Cytomembrane‐Mediated Transport of Metal Ions with Biological Specificity
por: Zhang, Ming‐Kang, et al.
Publicado: (2019) -
The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8(+) T Cell Responses
por: Kim, Cheol Gyun, et al.
Publicado: (2019) -
Cytomembrane Trafficking Pathways of Connexin 26, 30, and 43
por: Zong, Yan-Jun, et al.
Publicado: (2023) -
Engineering anti-cancer nanovaccine based on antigen cross-presentation
por: Warrier, Vaishnavi U., et al.
Publicado: (2019) -
An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer
por: Zhang, Yunting, et al.
Publicado: (2023)